Hui Cheng
- Cancer Research top 10%
- NF-κB Signaling Pathways 7
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 6
- Microbiology top 5%
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 6
- Internal Medicine top 10%
- Otorhinolaryngology top 5%
-
- RNA modifications and cancer 9
- Cancer-related gene regulation 6
- Cell death mechanisms and regulation 5
-
- Cancer-related Molecular Pathways 6
Hui Cheng
84 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 125
- Cancer Research 290
- Microbiology 103
- Molecular Medicine 81
- Internal Medicine 50
- Otorhinolaryngology 57
Countries citing papers authored by Hui Cheng
This map shows the geographic impact of Hui Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Cheng more than expected).
Fields of papers citing papers by Hui Cheng
This network shows the impact of papers produced by Hui Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Cheng. The network helps show where Hui Cheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 9 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 2 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 11 | |
| 11 | 2019 | 26 | |
| 12 | 2019 | 25 | |
| 13 | 2018 | 35 | |
| 14 | 2016 | 56 | |
| 15 | 2015 | 54 | |
| 16 | 2013 | 66 | |
| 17 | The impact of delivery mode on postpartum stress urinary incontinence in primiparas: a meta-analysis | 2012 | 1 |
| 18 | [Regulation and mechanism of Notch signaling pathway in small cell lung cancer]. | 2010 | 5 |
| 19 | 2008 | 10 | |
| 20 | The deoxyribonucleoside phosphotransferase of Trichomonas vaginalis | 1984 | 5 |
About Hui Cheng
Hui Cheng is a scholar working on Cancer Research, Molecular Medicine and Internal Medicine, having authored 97 papers that have together received 1.6k indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), NF-κB Signaling Pathways (7 papers), Cancer-related molecular mechanisms research (7 papers), Cancer-related Molecular Pathways (6 papers), Antibiotic Resistance in Bacteria (6 papers), MicroRNA in disease regulation (6 papers), Cancer-related gene regulation (6 papers) and Cell death mechanisms and regulation (5 papers). The work is most often cited by research in Cancer Research (290 citations), Microbiology (103 citations) and Molecular Medicine (81 citations). Hui Cheng has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Han Jiang, Jiehong Fang, Timothy J. Larson, Carter Van Waes, Eugene G. Mueller, Peter M. Palenchar, Gary A. Jarvis, Jiong Zou, Guangrong Huang and Zhong Chen. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.